SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : NTEG- Bloodless Glucose Monitor

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Tevyah who wrote (2)9/28/1996 1:35:00 AM
From: Don Savage   of 176
 
Ken, I really don,t know to much about
the company yet, but I,ve read they went NASDAQ on
June 26th, 1996 with an initial public offering of
3,000,000 mil. shares. Here's the news from that day.

Integ's initial public offering of three million shares priced at 9-1/2 on Wednesday afternoon, and the company started
trading about an hour before close, said underwriter Piper Jaffray.
The offering priced below the estimated price range of $10-11 per share, which was down from an initial price range of $12-14 per share.
Integ is developing a painless hand-held glucose monitoring product for use by people with diabetes.

I,ll try to get an investment package from the company an keep this thread updated. With only a few million shares outstanding it looks
like if they get approval for the product this stock could fly.
Back to Integ Inc news page
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext